CN102892422A - 用于抗炎治疗的含硅的可生物降解的材料 - Google Patents
用于抗炎治疗的含硅的可生物降解的材料 Download PDFInfo
- Publication number
- CN102892422A CN102892422A CN2011800112730A CN201180011273A CN102892422A CN 102892422 A CN102892422 A CN 102892422A CN 2011800112730 A CN2011800112730 A CN 2011800112730A CN 201180011273 A CN201180011273 A CN 201180011273A CN 102892422 A CN102892422 A CN 102892422A
- Authority
- CN
- China
- Prior art keywords
- interleukin
- disease
- siliceous
- beta
- biodegradable material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/62227—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products obtaining fibres
- C04B35/62231—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products obtaining fibres based on oxide ceramics
- C04B35/6224—Fibres based on silica
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/624—Sol-gel processing
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
- C04B35/62605—Treating the starting powders individually or as mixtures
- C04B35/62625—Wet mixtures
- C04B35/6263—Wet mixtures characterised by their solids loadings, i.e. the percentage of solids
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
- C04B35/62605—Treating the starting powders individually or as mixtures
- C04B35/62625—Wet mixtures
- C04B35/62635—Mixing details
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
- C04B35/62605—Treating the starting powders individually or as mixtures
- C04B35/62685—Treating the starting powders individually or as mixtures characterised by the order of addition of constituents or additives
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/30—Constituents and secondary phases not being of a fibrous nature
- C04B2235/44—Metal salt constituents or additives chosen for the nature of the anions, e.g. hydrides or acetylacetonate
- C04B2235/441—Alkoxides, e.g. methoxide, tert-butoxide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Manufacturing & Machinery (AREA)
- Ceramic Engineering (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Structural Engineering (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Otolaryngology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Transplantation (AREA)
- AIDS & HIV (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
Abstract
Description
Claims (7)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102010008982.6 | 2010-02-24 | ||
DE102010008982A DE102010008982A1 (de) | 2010-02-24 | 2010-02-24 | Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie |
PCT/EP2011/052560 WO2011104214A1 (de) | 2010-02-24 | 2011-02-22 | Siliciumhaltiges, biologisch degradierbares material zur anti-inflammatorischen therapie |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102892422A true CN102892422A (zh) | 2013-01-23 |
CN102892422B CN102892422B (zh) | 2017-04-19 |
Family
ID=43795179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201180011273.0A Active CN102892422B (zh) | 2010-02-24 | 2011-02-22 | 用于抗炎治疗的含硅的可生物降解的材料 |
Country Status (12)
Country | Link |
---|---|
US (2) | US20130115186A1 (zh) |
EP (1) | EP2538949B1 (zh) |
JP (1) | JP2013520462A (zh) |
KR (1) | KR20130008566A (zh) |
CN (1) | CN102892422B (zh) |
AU (1) | AU2011219896A1 (zh) |
BR (1) | BR112012021334A2 (zh) |
CA (1) | CA2790646C (zh) |
DE (1) | DE102010008982A1 (zh) |
MX (1) | MX2012009718A (zh) |
RU (1) | RU2571504C2 (zh) |
WO (1) | WO2011104214A1 (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2427179A4 (en) | 2009-05-04 | 2013-09-11 | Psivida Inc | POROUS PARTICLES FOR THE RELEASE OF SILICIUM MEDICINES |
DE102010008981A1 (de) * | 2010-02-24 | 2011-08-25 | Bayer Innovation GmbH, 40225 | Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie |
IN2013MN00758A (zh) | 2010-11-01 | 2015-06-12 | Psivida Inc | |
JP2016512839A (ja) | 2013-03-15 | 2016-05-09 | シヴィダ・ユーエス・インコーポレイテッドPsivida Us, Inc. | 治療物質の送達のための生体内分解性ケイ素系組成物 |
US11759473B2 (en) | 2018-02-16 | 2023-09-19 | American Nano, LLC | Topical compositions incorporating silica fibers |
US20190255223A1 (en) | 2018-02-16 | 2019-08-22 | American Nano, LLC | Silica fiber compositions and methods of use |
US11135806B2 (en) | 2018-02-16 | 2021-10-05 | American Nano Llc. | Compositions incorporating silica fibers |
US10111783B1 (en) | 2018-02-16 | 2018-10-30 | American Nano, LLC | Silica fiber composition and method of use |
CN111971429B (zh) * | 2018-03-16 | 2022-12-16 | 美国纳米有限责任公司 | 掺入二氧化硅纤维的组合物 |
WO2019179611A1 (en) * | 2018-03-20 | 2019-09-26 | Sil'innov Scrl | Stable, bioavailable silicon complex for medical use |
US20220211898A1 (en) * | 2019-09-10 | 2022-07-07 | American Nano, LLC | Silica fiber hemostatic devices and methods |
CN113332488A (zh) * | 2021-05-31 | 2021-09-03 | 南昌智产科技有限公司 | 一种医用硅凝胶泡沫敷料及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1136316A (zh) * | 1994-09-30 | 1996-11-20 | 爱克希莫尔公司 | 生物活性硅化合物及其应用 |
CN101583574A (zh) * | 2007-01-15 | 2009-11-18 | 拜尔创新有限责任公司 | 用于制备可生物降解和/或可吸收性硅凝胶材料的硅溶胶材料、其制备和用途 |
WO2010006708A1 (de) * | 2008-07-16 | 2010-01-21 | Bayer Innovation Gmbh | Kieselsol-material mit mindestens einem therapeutisch aktiven wirkstoff zur herstellung von biologisch degradierbaren und/oder resorbierbaren kieselgel-materialen für die humanmedizin und/oder medizintechnik |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2588109B2 (ja) | 1993-03-19 | 1997-03-05 | 日本臓器製薬株式会社 | 鎮痛剤 |
JPH0751354A (ja) * | 1993-08-20 | 1995-02-28 | Ube Ind Ltd | ポリエステル人工血管及びその製造方法 |
JPH0751356A (ja) * | 1993-08-20 | 1995-02-28 | Ube Ind Ltd | 抗血栓性医療用具及び抗血栓性付与方法 |
DE19609551C1 (de) | 1996-03-12 | 1997-07-17 | Fraunhofer Ges Forschung | Biologisch degradierbare und/oder biologisch resorbierbare (Endlos)Fasern, Verfahren zu deren Herstellung und deren Verwendung als Verstärkungsfasern |
FR2799758B1 (fr) | 1999-10-15 | 2002-05-17 | Exsymol Sa | Complexe a base d'acide orthosilicique biologiquement assimilable, se presentant sous forme solide, stable et concentree, et procede de preparation |
DE19959750C1 (de) | 1999-12-11 | 2001-05-31 | Axel Thierauf | Verfahren zur Herstellung eines Hautimplantats, insbesondere Eigenhaut-Implantat und nach dem Verfahren hergestelltes Implantat |
CN1312080A (zh) | 2000-02-18 | 2001-09-12 | 日本脏器制药株式会社 | 含有脂肪酸的组合物 |
DE10126137C1 (de) | 2001-05-29 | 2002-11-07 | Andreas Haisch | Verfahren zur Herstellung von Zellen, Geweben und Organen |
EP1517874B1 (en) | 2002-05-31 | 2007-05-02 | Sabalo N.V. | Aqueous solution of non-colloidal silicic acid and boric acid |
EP1391426A1 (en) * | 2002-08-12 | 2004-02-25 | Bio Minerals N.V. | Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
DE102004063599B4 (de) | 2004-12-30 | 2007-07-12 | Bayer Innovation Gmbh | Verkürzte Wundheilungsprozesse mittels neuartiger Faservliese |
ES2731298T3 (es) * | 2005-05-27 | 2019-11-14 | Univ North Carolina Chapel Hill | Partículas de liberación de óxido nítrico para agentes terapéuticos de óxido nítrico y aplicaciones biomédicas |
DE102007026043B4 (de) | 2007-06-04 | 2018-08-16 | Jiangsu Synecoun Medical Technology Co., Ltd. | Nicht-toxisches Polyethoxysiloxan-Material zur Herstellung von biologisch resorbierbares und/oder bioaktives Polyethoxysiloxan-Material enthaltenden Artikeln, dessen Herstellung und Verwendung |
US20100278935A1 (en) | 2007-07-30 | 2010-11-04 | Stacey William C | Immune System Modulator Formulation |
EP3939599A3 (en) | 2007-10-15 | 2022-03-16 | HS Pharmaceuticals, LLC | Silicate containing compositions and methods of treatment |
DE102007061874A1 (de) | 2007-12-19 | 2009-06-25 | Bayer Innovation Gmbh | Nicht-toxisches Polysiloxan-Material zur Herstellung von biologisch resorbierbaren und/oder bioaktiven Polysiloxan-Material enthaltenden Artikeln, dessen Herstellung und Verwendung |
-
2010
- 2010-02-24 DE DE102010008982A patent/DE102010008982A1/de active Pending
-
2011
- 2011-02-22 US US13/579,498 patent/US20130115186A1/en not_active Abandoned
- 2011-02-22 CA CA2790646A patent/CA2790646C/en active Active
- 2011-02-22 KR KR1020127024616A patent/KR20130008566A/ko not_active Application Discontinuation
- 2011-02-22 MX MX2012009718A patent/MX2012009718A/es not_active Application Discontinuation
- 2011-02-22 RU RU2012140380/15A patent/RU2571504C2/ru active
- 2011-02-22 JP JP2012554315A patent/JP2013520462A/ja active Pending
- 2011-02-22 WO PCT/EP2011/052560 patent/WO2011104214A1/de active Application Filing
- 2011-02-22 EP EP11706800.7A patent/EP2538949B1/de not_active Not-in-force
- 2011-02-22 CN CN201180011273.0A patent/CN102892422B/zh active Active
- 2011-02-22 AU AU2011219896A patent/AU2011219896A1/en not_active Abandoned
- 2011-02-22 BR BR112012021334A patent/BR112012021334A2/pt not_active IP Right Cessation
-
2016
- 2016-05-10 US US15/150,919 patent/US10258644B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1136316A (zh) * | 1994-09-30 | 1996-11-20 | 爱克希莫尔公司 | 生物活性硅化合物及其应用 |
CN101583574A (zh) * | 2007-01-15 | 2009-11-18 | 拜尔创新有限责任公司 | 用于制备可生物降解和/或可吸收性硅凝胶材料的硅溶胶材料、其制备和用途 |
WO2010006708A1 (de) * | 2008-07-16 | 2010-01-21 | Bayer Innovation Gmbh | Kieselsol-material mit mindestens einem therapeutisch aktiven wirkstoff zur herstellung von biologisch degradierbaren und/oder resorbierbaren kieselgel-materialen für die humanmedizin und/oder medizintechnik |
Also Published As
Publication number | Publication date |
---|---|
JP2013520462A (ja) | 2013-06-06 |
CN102892422B (zh) | 2017-04-19 |
MX2012009718A (es) | 2012-09-12 |
EP2538949B1 (de) | 2015-01-21 |
CA2790646A1 (en) | 2011-09-01 |
US20130115186A1 (en) | 2013-05-09 |
EP2538949A1 (de) | 2013-01-02 |
DE102010008982A1 (de) | 2011-08-25 |
AU2011219896A1 (en) | 2012-09-27 |
WO2011104214A1 (de) | 2011-09-01 |
US20170020915A1 (en) | 2017-01-26 |
RU2571504C2 (ru) | 2015-12-20 |
US10258644B2 (en) | 2019-04-16 |
RU2012140380A (ru) | 2014-03-27 |
BR112012021334A2 (pt) | 2019-09-24 |
CA2790646C (en) | 2018-08-28 |
KR20130008566A (ko) | 2013-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102892422A (zh) | 用于抗炎治疗的含硅的可生物降解的材料 | |
CN105451713B (zh) | 二氧化硅水凝胶复合材料 | |
AU2021105727A4 (en) | A method of preparation of Silk Fibroins coated with Hybrid chitosan-ZnO nanoparticles for wound dressing. | |
CN102834101A (zh) | 用于促血管生成疗法的含硅的可生物降解的材料 | |
CN109966540A (zh) | 一种纳米甲壳素复合海藻酸钙医用敷料的制备方法及应用 | |
Sun et al. | The recent progress of the cellulose-based antibacterial hydrogel | |
CN105919978A (zh) | 一种阿莫西林微球缓释胶囊制备方法 | |
CN105079860B (zh) | 一种具有抑菌促进药物透皮吸收的透气保湿敷料以及制备方法 | |
CN106215221A (zh) | 壳寡糖‑明胶‑镁黄长石纳米纤维生物敷料及其制备方法 | |
CN102670607A (zh) | 复方盐酸氨溴索组合物及其制备方法 | |
CN103285419B (zh) | 一种制备医用创面修复材料的方法 | |
CN108175873A (zh) | 一种用于麻醉手术后的抗菌医用敷料及其制备方法 | |
CN115120701A (zh) | 一种改善抑郁的组合物及其制备方法和应用 | |
WO2004075906A1 (ja) | 抗炎症剤及び抗炎症性医療材料 | |
WO2004089430A1 (fr) | Nouveau produit d'amelioration de cicatrisation de la peau | |
TW202138488A (zh) | 一種聚麩胺酸生物列印墨水的製造方法 | |
RU2185807C1 (ru) | Пролонгированные лекарственные формы местного действия, оказывающие активирующее влияние на иммунную систему | |
CN114869843B (zh) | 一种高交联裸藻多糖凝胶的制备方法 | |
CN114306621B (zh) | 一种携带核酸药物的细胞外泌体及其制备方法与在免疫治疗中的应用 | |
CN107198728A (zh) | 用于治疗小儿上呼吸道感染的中药制剂及其制备方法 | |
CN108186774A (zh) | 一种具有消炎和抗病毒作用的敷贴药物及其制备方法 | |
Yu et al. | Multifunctional hyaluronic acid/gelatin methacryloyl core-shell microneedle for comprehensively treating oral mucosal ulcers | |
CN106974926B (zh) | 一种用于治疗压疮的药物组合物及其制备方法和用途 | |
CN118078989A (zh) | 一种抗幽门螺杆菌口服制剂及其制备方法 | |
TW202327657A (zh) | 三維網狀水性凝膠及其製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU XINLIKANG MEDICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: SUZHOU XINLIKANG PHARMACEUTICAL TECHNOLOGY CO., LTD. Effective date: 20150813 Owner name: SUZHOU XINLIKANG PHARMACEUTICAL TECHNOLOGY CO., LT Free format text: FORMER OWNER: BAYER INNOVATION GMBH Effective date: 20150813 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20150813 Address after: 225300 Jiangsu city of Taizhou province Chinese pharmaceutical Road No. 50 west of G60 City Applicant after: Jiangsu Xinlikang Medical Technology Co.,Ltd. Address before: 112, room 2, building 215021, Lu Xu village, Suzhou, Suzhou Industrial Zone, Jiangsu, China Applicant before: Suzhou Xin Li Kang Pharmaceutical Technology Co.,Ltd. Effective date of registration: 20150813 Address after: 112, room 2, building 215021, Lu Xu village, Suzhou, Suzhou Industrial Zone, Jiangsu, China Applicant after: Suzhou Xin Li Kang Pharmaceutical Technology Co.,Ltd. Address before: Germany Leverkusen Applicant before: Bayer Innovation GmbH |
|
GR01 | Patent grant | ||
GR01 | Patent grant |